- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07647900
Photography-Based Intervention for Children With Attention Deficit Hyperactivity Disorder
Photography-Based Intervention to Improve Emotion Wellbeing and Symptoms in Children With Attention Deficit Hyperactivity Disorder
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Hong Kong
-
Hong Kong, Hong Kong, Hong Kong
- Ka Po Wong
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- ethnic Chinese aged between 8-12 years old
- documented diagnosis of ADHD by a psychiatrist according to the ICD-10 HKD or DSM-5 criteria
- stable on current treatment for ADHD eight weeks before baseline
- ability to read Chinese and listen to Cantonese
- able to operate a camera; 8) willingness of
- their guardians to provide informed consent
Exclusion Criteria:
- general intellectual functioning below the low-average range (estimated IQ < 80)
- unstable screened via parental declaration and medication review
- comorbid psychiatric disorder, severe physical or learning disability that prevents functional participation in photography tasks
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Photography-based intervention group
The participants in this group will have a six-weekly photography course.
Each session is about 60 minutes.
Four participants will be arranged together to conduct one session.
In each session, a photographer will teach the participants basic photography skills and give a theme for the participants to take photos which will be used for sharing in the next session.
Themes mainly are emotions and objects.
In the sharing, the photographer will ask the participants to explain the reasons why take these photos and the photographer will explain the different types of emotions to the participants based on the themes.
The participants can express their views and feelings regarding their photos.
|
The programme follows a structured progression across six sessions, each building upon previous learning whilst introducing new skills and concepts. For the first session, participants build rapport and introduce photography techniques (composition, lighting) alongside emotional awareness to capture basic emotional states. For the second and third sessions, they explore personal emotions and triggers through self-portraits and visual documentation. For the fourth and fifth sessions, they focus on the ADHD journey via strength-based photo narratives and collaborative projects to enhance peer support and social learning. In the last session, they consolidated skills into personal visual toolkits for ongoing regulation, concluding with a final project presentation and maintenance planning. |
|
No Intervention: Waitlist control group
The participants maintained their Treatment-as-Usual (TAU).
Participants in the waitlist group received the identical photography-based psychoeducation program immediately after the post-intervention assessment.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Emotional Awareness
Time Frame: From enrollment to the end of treatment at 8 weeks and 3-month follow-up
|
Participants' emotional functioning was evaluated by a licensed clinical psychologist using an adapted version of the Emotion Awareness Questionnaire (EAQ; Rieffe et al., 2007).
To fit the clinical evaluation context and focus specifically on the core processing stages of emotion identification and expression, the questionnaire was adapted into an informant-report format consisting of two selected subscales (10 items in total): Verbal Sharing of Emotions (3 items) and Differentiating Emotions (7 items).
Items in this adapted version were rated on a 4-point Likert scale ranging from 1 (never) to 4 (always).
|
From enrollment to the end of treatment at 8 weeks and 3-month follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Emotion Recognition
Time Frame: From enrollment to the end of treatment at 8 weeks and 3-month follow up
|
Participants' ability to accurately identify emotional states from non-verbal cues was evaluated using a customized, 7-item Facial Emotion Recognition Task (FERT) based on the universal emotional categories established by Ekman and Friesen (1975).
Children were presented with seven distinct facial-expression stimuli, each representing a specific emotion category: happiness, surprise, anger, contempt, disgust, fear, and sadness.
The facial stimuli were presented on a computer screen by a licensed clinical psychologist.
For each item, participants were instructed to identify or label the displayed emotion.
The performance was scored based on overall accuracy (total correct answers out of 7), with higher scores indicating a better capacity for facial emotion recognition.
|
From enrollment to the end of treatment at 8 weeks and 3-month follow up
|
|
Happiness
Time Frame: From enrollment to the end of treatment at 8 weeks and 3-month follow-up
|
The 4-item Subjective Happiness Scale (SHS; Lyubomirsky & Lepper, 1999) was utilized to measure subjective happiness.
Respondents rated items on a 7-point Likert scale ( 1 = strongly disagree 1=strongly disagree, 7 = strongly agree 7=strongly agree).
|
From enrollment to the end of treatment at 8 weeks and 3-month follow-up
|
|
ADHD symptoms
Time Frame: From enrollment to the end of treatment at 8 weeks and 3-month follow up
|
The teacher-rated Chinese version of the Swanson, Nolan, and Pelham, Version IV (SNAP-IV-18) 18-item scale (Swanson, 1992), which assesses inattention (9 items) and hyperactivity/ impulsivity (9 items).
A 4-point Likert scale will be used, ranging from 0 (not at all) to 3 (very much).
|
From enrollment to the end of treatment at 8 weeks and 3-month follow up
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HSEARS20230714001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Attention Deficit Hyperactivity Disorder
-
King's College LondonActive, not recruitingAttention-Deficit Hyperactivity Disorder | Attention-Deficit Hyperactivity Disorder SymptomsUnited Kingdom
-
Cingulate TherapeuticsSuspendedPhase 3 Efficacy and Safety Laboratory Classroom Study in Pediatrics (6-12) With ADHD Using CTx-1301ADHD | Attention Deficit Hyperactivity Disorder | Attention Deficit Disorder With Hyperactivity | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit HyperactivityUnited States
-
Ornit CohenUnknownAttention Deficit Hyperactivity Disorder | Attention Deficit Disorder With Hyperactivity | Attention Deficit Disorder | Attention Deficit Disorders With Hyperactivity | Attention Deficit Hyperactivity DisordersIsrael
-
Cingulate TherapeuticsPremier Research Group plcCompletedADHD | Attention Deficit Hyperactivity Disorder | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit HyperactivityUnited States
-
Central South UniversityRecruitingAttention-Deficit/Hyperactivity DisorderChina
-
Qbtech ABEnrolling by invitationAttention Deficit Disorder With Hyperactivity (ADHD) | Attention Deficit Disorder (ADD)United States
-
Universidade do Sul de Santa CatarinaAssociação Brasileira de Cannabis MedicinalRecruitingAttention-Deficit/Hyperactivity Disorder (ADHD)Brazil
-
Nanjing Medical UniversityRecruitingAdult Attention Deficit Hyperactivity DisorderChina
-
Children's Hospital Medical Center, CincinnatiPatient-Centered Outcomes Research Institute; Children's Hospital of Philadelphia and other collaboratorsNot yet recruitingAttention-Deficit/Hyperactivity Disorder (ADHD)United States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAttention Deficit Disorder With HyperactivityUnited States
Clinical Trials on Photography-based psychoedication
-
Centre Hospitalier Universitaire de NiceTerminatedPremature BirthFrance
-
IDx LLCThe University of Texas Health Science Center, Houston; University of Pennsylvania and other collaboratorsCompletedDiabetic RetinopathyUnited States
-
Yale-NUS CollegeUnknownFood Photography | Non-Food Photography | No Phone UseSingapore
-
Yale-NUS CollegeUnknownFood Photography | Non-Food Photography | No Phone UseSingapore
-
Yun-Chen ChangChina Medical University, ChinaNot yet recruitingBreast Cancer | Randomized Controlled Trial | Breast Cancer FemaleTaiwan
-
Topcon CorporationCompleted
-
Second Affiliated Hospital, School of Medicine,...Recruiting
-
Northwestern UniversityTerminatedLichen Sclerosus et Atrophicus | Lichen SclerosusUnited States
-
Queen Victoria Hospital NHS Foundation TrustTerminated